
Aurobindo Pharma Ltd
NSE: AUROPHARMA BSE: 524804
₹1239.70
(5.87)%
Tue, 03 Feb 2026, 08:48 am
Market Cap704.11B
PE Ratio21.04
Dividend0.33
Financials
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Deprecation and amortization | -721.30M | -997.30M | -1.00B | -1.28B | -1.49B | -1.72B | -2.01B | -2.49B | -3.13B | -3.33B | -3.92B | -4.28B | -5.58B | -6.68B | -9.67B | -10.55B | -11.27B | -12.45B | -14.92B | -15.91B |
| Accumulated depreciation, total | -2.64B | -3.08B | -4.07B | -5.54B | -6.64B | -6.40B | -7.98B | -9.90B | -12.30B | -15.37B | -3.46B | -7.17B | -11.84B | -17.35B | -24.83B | -31.46B | -36.77B | -53.74B | -62.10B | -63.24B |
| Cash from operating activities | -443.60M | -323.40M | 1.42B | 761.00M | 3.75B | 3.01B | 2.56B | 1.65B | 5.56B | 11.78B | 13.46B | 32.37B | 19.08B | 14.97B | 42.76B | 33.00B | 50.23B | 24.22B | 24.65B | 38.52B |
| Funds from operations | 1.12B | 2.34B | 2.69B | 4.10B | 6.36B | 7.72B | 3.84B | 5.99B | 16.15B | 20.20B | 24.26B | 27.03B | 30.31B | 30.07B | 39.69B | 43.67B | 34.65B | 35.17B | 41.40B | 50.96B |
| Net income (cash flow) | 697.00M | 2.01B | 2.38B | 513.10M | 5.61B | 5.74B | -1.24B | 2.94B | 11.73B | 15.76B | 20.25B | 23.02B | 24.23B | 23.65B | 28.45B | 53.35B | 26.48B | 19.27B | 31.73B | 34.86B |
| Depreciation & amortization (cash flow) | 721.30M | 997.30M | 1.00B | 1.28B | 1.49B | 1.72B | 2.01B | 2.49B | 3.13B | 3.33B | 3.92B | 4.28B | 5.58B | 6.68B | 9.67B | 10.55B | 11.27B | 12.45B | 15.22B | 16.49B |
| Depreciation/depletion | 674.20M | 885.90M | 977.00M | 1.16B | 1.31B | 1.45B | 1.64B | 2.03B | 2.41B | 3.05B | 3.44B | 3.78B | 4.67B | 5.69B | 7.31B | 8.02B | 7.98B | 8.33B | 9.18B | 11.28B |
| Amortization | 47.10M | 111.40M | 26.80M | 117.20M | 185.50M | 266.40M | 362.90M | 460.00M | 715.10M | 272.70M | 480.40M | 497.30M | 908.30M | 994.20M | 2.36B | 2.54B | 3.29B | 4.11B | 6.04B | 5.21B |
| Deferred taxes (cash flow) | — | — | — | — | — | — | — | — | — | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-cash items | -585.10M | -713.50M | -1.23B | 2.10B | -2.65B | -1.98B | 3.97B | -237.10M | -2.30B | -4.80B | -7.11B | -7.85B | -7.68B | -7.52B | -7.41B | -40.32B | -10.34B | -3.40B | -17.62B | -16.20B |
| Changes in working capital | -1.56B | -2.67B | -1.27B | -3.34B | -2.61B | -4.71B | -1.28B | -4.35B | -10.59B | -8.42B | -10.79B | 5.34B | -11.23B | -15.10B | 3.08B | -10.67B | 15.58B | -10.95B | -16.75B | -12.44B |
| Cash from investing activities | -2.57B | -5.50B | -1.20B | -4.29B | -4.09B | -5.98B | -5.69B | -2.48B | -8.22B | -14.24B | -14.55B | -18.03B | -19.54B | -29.03B | -15.89B | 5.80B | -32.37B | -41.24B | -45.37B | -22.46B |
| Capital expenditures | -2.22B | -3.32B | -2.46B | -4.83B | -4.20B | -7.16B | -5.71B | -2.73B | -3.90B | -7.68B | -15.66B | -16.94B | -15.30B | -15.59B | -14.31B | -18.74B | -27.05B | -27.20B | -35.62B | -25.20B |
| Capital expenditures - fixed assets | -2.22B | -3.32B | -2.46B | -4.83B | -4.20B | -7.16B | -5.71B | -2.73B | -3.90B | -7.68B | -15.66B | -16.94B | -13.23B | -14.26B | -14.31B | -18.74B | -27.05B | -24.04B | -35.62B | -19.68B |
| Capital expenditures - other assets | 0 | 0 | 0 | — | 0 | — | — | — | — | — | — | — | -2.07B | -1.33B | -483.40M | — | — | -3.17B | — | -5.52B |
| Cash from financing activities | 4.35B | 7.71B | -1.55B | 2.47B | -239.30M | 4.52B | 1.94B | 2.20B | 2.11B | 1.67B | 4.49B | -18.58B | 9.38B | 20.71B | -18.21B | -13.17B | -29.51B | 19.26B | 10.51B | 5.63B |
| Free cash flow | -2.67B | -3.64B | -1.05B | -4.07B | -445.30M | -4.15B | -3.15B | -1.09B | 1.66B | 4.10B | -2.19B | 15.43B | 5.85B | 711.20M | 28.45B | 14.26B | 23.19B | 183.70M | -10.97B | 18.84B |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800